Foliglurax
- Generic Name
- Foliglurax
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H23N3O3S
- CAS Number
- 1883329-53-0
- Unique Ingredient Identifier
- FR50CP1D6W
- Background
Foliglurax is under investigation in clinical trial NCT02639221 (A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects).
- Associated Conditions
- -
- Associated Therapies
- -
Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects
- First Posted Date
- 2020-02-19
- Last Posted Date
- 2020-04-24
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 20
- Registration Number
- NCT04275115
- Locations
- 🇫🇷
Biotrial, Rennes, France
Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD)
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2020-12-09
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 6
- Registration Number
- NCT04175132
- Locations
- 🇸🇪
Karolinska Institutet, Stockholm, Sweden
What the Body Does to Foliglurax in Healthy Volunteers
- First Posted Date
- 2019-07-01
- Last Posted Date
- 2019-11-04
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 6
- Registration Number
- NCT04002895
- Locations
- 🇬🇧
GB1050 Covance, Leeds, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath